From Nasdaq Media Group: 2024-03-28 14:00:03

Achieve Life Sciences, Inc. (ACHV) is set to report earnings with a forecasted consensus earnings per share of $-0.31 for the quarter ending December 31, 2023, a 62.65% increase year-over-year. Zacks Investment Research indicates a positive earnings growth potential compared to industry competitors.

Ascent Industries Co. (ACNT) is also reporting earnings, with a consensus forecast of $-0.08 per share for the same quarter, a 900.00% decrease from the previous year. This suggests a significant challenge amidst industry peers in terms of earnings growth.

American Resources Corporation (AREC) anticipates a earnings per share of $-0.04 for the quarter ending December 31, 2023, marking a 63.64% increase from the same period last year. Despite missing expectations in the past, Zacks reports a favorable outlook based on the Price to Earnings ratio.

Accelerate Diagnostics, Inc. (AXDX) is expected to report earnings and achieve a consensus earnings per share forecast of $-0.62, showing a 55.71% increase from the previous year. Zacks Investment Research highlights a strong Price to Earnings ratio compared to industry peers.

Cepton, Inc. (CPTN) prepares to report with a consensus earnings per share forecast of $-0.54 for the quarter ending December 31, 2023, showcasing a 46.00% increase from the same quarter last year. The company has room for improvement based on past performance versus analyst expectations.

Torrid Holdings Inc. (CURV) is set to report with a consensus earnings per share forecast of $-0.08 for the quarter ending January 31, 2024, indicating a 100.00% decrease from the previous year. The company aims to overcome past earnings misses and outperform industry counterparts.

Dare Bioscience, Inc. (DARE) will report earnings with a consensus forecast of $-0.12 per share, showing a 36.84% increase from the same quarter last year. Zacks Investment Research indicates a potential for higher earnings growth compared to industry competitors based on the Price to Earnings ratio.

Danimer Scientific, Inc. (DNMR) is expected to report earnings with a consensus forecast of $-0.39 per share for the quarter ending December 31, 2023, a 39.29% decrease from the prior year. Zacks notes past negative earnings surprises as a pivotal factor to monitor in upcoming reports.

Dyadic International, Inc. (DYAI) will release earnings reporting a consensus forecast of $-0.06 per share for the quarter ending December 31, 2023, a 14.29% increase year-over-year. The company’s strong Price to Earnings ratio positions them for potential earnings growth amidst industry peers.

Forian Inc. (FORA) is expected to report earnings with a consensus forecast of $0.00 per share for the quarter ending December 31, 2023, displaying a 100.00% increase from the same quarter last year. Zacks highlights a positive Price to Earnings ratio compared to industry standards.

Helius Medical Technologies, Inc. (HSDT) anticipates reporting earnings with a consensus forecast of $-4.05 per share for the quarter ending December 31, 2023, a 52.35% increase from the prior year. Analysts suggest a cautious approach as the company aims to bridge prior earnings shortfalls.

Intellinetics, Inc. (INLX) gears up to report earnings with a consensus forecast of $0.04 per share for the quarter ending December 31, 2023. The company aims to exceed expectations and solidify positive earnings growth based on prior performance against analyst forecasts.



Read more at Nasdaq Media Group:: After-Hours Earnings Report for March 28, 2024 : ACHV, ACNT, AREC, AXDX, CPTN, CURV, DARE, DNMR, DYAI, FORA, HSDT, INLX